Price, DavidBeekman, Maarten j. h. i.Mattarucco, Walter javierBarriga-Acevedo, Rocio martinaWang, Hao-ChienDiaz, Dina v.Khattab, AdelPacheco gallego, ManuelAl zaabi, AshrafFarouk, HishamAttar-Zadeh, Darush2024-11-042024-11-042024-11-01Price, D, Beekman, M J H I, Mattarucco, W J, Barriga-Acevedo, R M, Wang, H-C, Diaz, D V, Khattab, A, Pacheco gallego, M, Al zaabi, A, Farouk, H & Attar-Zadeh, D 2024, 'Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes : a post hoc analysis of the SABINA III study', npj Primary Care Respiratory Medicine, vol. 34, no. 1, 34. https://doi.org/10.1038/s41533-024-00397-42055-1010crossref: 10.1038/s41533-024-00397-4https://hdl.handle.net/2164/24539Acknowledgements AstraZeneca funded all the SABINA studies and was involved in designing the study, developing the study protocol, conducting the study, and performing the analyses. AstraZeneca was given the opportunity to review the manuscript before submission and funded medical writing support. Writing and editorial support was provided by Praveen Kaul, PhD, of Cactus Life Sciences (part of Cactus Communications), Mumbai, India, in accordance with Good Publication Practice (GPP 2022) guidelines (https://www.acpjournals.org/doi/10.7326/M22-1460) and fully funded by AstraZeneca.101627990engSDG 3 - Good Health and Well-beingasthmahealth policyR MedicineSupplementary InformationRJournal article10.1038/s41533-024-00397-4341